Loading
The OncoPatch applicator is a patch from OncoPatch that treats basal cell and squamous cell skin cancers with short-range beta radiation in the doctor's office. It is in clinical studies.
OncoPatch describes its applicator as a non-invasive, in-office treatment for basal cell and squamous cell carcinoma of the skin using low-energy beta therapy, held in place with a silicone bandage, with clinical studies ongoing. STTR Phase I grant 1R41CA310335-01 funds work on activated GaP-32 as the radiation source; the award abstract contrasts it with conventional radiotherapy for these cancers, which is divided into 8 to 20 fractions over 3 to 6 weeks.
An applicator carrying a low-energy beta emitter is placed on the skin lesion, so that the short-range radiation treats the tumour with little penetration into deeper tissue; the NCI award concerns activated GaP-32 as the source.
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Query for this drug: (TITLE:"OncoPatch low-energy beta therapy applicator" OR ABSTRACT:"OncoPatch low-energy beta therapy applicator") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about OncoPatch low-energy beta therapy applicator, not a curated reading list.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/